Bio-Rad Laboratories, Inc.Class A (BIO)
Underlying price
$379.82+2.89% today
Stock stats
- Market cap
- $9.87B
- Previous close
- $369.14
- Open
- $368.07
- Day's range
- $363.96 – $381.78
- 52-week range
- $236.73 – $396.23
- Volume
- 279K
- Avg volume
- 268K
- P/E ratio
- 44.38
About Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
- Ticker
- BIO
- Asset class
- Equity
- Tokenized by
- 0 issuers
- Sector
- Technology
- Industry
- Laboratory Analytical Instruments
- Employees
- 7,450
- Website
- bio-rad.com